SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-040482
Filing Date
2017-08-04
Accepted
2017-08-04 11:05:25
Documents
5
Period of Report
2017-08-14
Effectiveness Date
2017-08-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A v471732_def14a.htm DEF 14A 135870
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v471732_pc1.jpg GRAPHIC 871474
5 GRAPHIC v471732_pc2.jpg GRAPHIC 525089
  Complete submission text file 0001144204-17-040482.txt   2060599
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32715 | Film No.: 171007405
SIC: 2835 In Vitro & In Vivo Diagnostic Substances